Female Contraceptive Market Global Research and Analysis by 2020 Oct-2016

Global Female Contraceptive Market 2016-2020

Global Female Contraceptive Market 2016-2020 is the latest addition to Sandlerresearch.org industry
research reports collection.
Adolescent fertility regulation and pregnancy prevention are important healthcare issues today.
Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need
for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior
in adolescence results in a pattern for the rest of an individual’s life. The absence of sexual and
reproductive healthcare programs for adolescents can result in unwanted pregnancies and unsafe
abortions.
The analysts forecast Global Female Contraceptive Market to grow at a CAGR of 3.48% during the
period 2016-2020.
Covered in this Report
This report covers the present scenario and the growth prospects of the global Female Contraceptive
Market for 2016-2020.
Inquire for more information @ http://www.sandlerresearch.org/inquire-beforebuying?rname=62103
Key vendors
Allergan
Merck Millipore
Pfizer
Teva Pharmaceuticals
Other prominent vendors
Afaxys
Agile Therapeutics
Ansell
Bayer Pharma
Caya
Ferring Pharmaceuticals
Female Health
Fuji Latex
HLL Lifecare